GO
Loading...

Search results for "lilly"

REFINE RESULTS

ANY FORMAT

Blog Posts
News
Slideshows
Special Reports
» Video
Wires

Press Releases

SEARCH RESULTS

About 9 results. Sort By: Date | Relevance
Facebook: Bull vs. Bear  

Discussing Facebook shares and their latest updates with Michael Graham, Canaccord Genuity, and Kim Forrest, Fortt Pitt Capital.
Source: CNBC.com
Red flags for biotech  

Dissecting the biotech space, with the Fast Money traders.
Source: CNBC.com
4 Stocks, 4 trades: Staples, Lululemon & more  

The FMHR traders take their positions on four stocks making news today, including a lower price target for Lululemon by Canaccord.
Source: CNBC.com
Betting on biotechs  

Les Funtleyder, ESquared, takes a look at biotech numbers and discusses the best opportunities in the space.
Source: CNBC.com
Biogen's big news: Alzheimer data on deck  

Biogen Idec is preparing to present data on its Alzheimer's drug this Friday. Details on the anticipated biotech news, with CNBC's Meg Tirrell.
Source: CNBC.com
Cramer: Market cross currents  

Mad Money host Jim Cramer discusses the many cross currents impacting the market, including earnings estimates that are just too high.
Source: CNBC.com
Faber Report: Battle over Salix  

CNBC's David Faber reports the latest on the competing bids for Salix Pharmaceuticals.
Source: CNBC.com
Bob Iger: Outlook for Disney strong  

Bob Iger, The Walt Disney Co. chairman and CEO, discusses the use of technology at theme parks; upcoming movies and business in China.
Source: CNBC.com
Billion dollar valuations and the tech industry  

We're in an environment where the public market is much more receptive to public IPOs, says Jeremy Liew, Lightspeed Venture Partner.
Source: CNBC.com